e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Airway obstruction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation
E. B. Bukreeva, E. A. Dementieva, S. V. Nesterovich, G. A. Suchanova, G. N. Seitova (Tomsk, Russia)
Source:
Annual Congress 2003 - Airway obstruction
Session:
Airway obstruction
Session type:
Thematic Poster Session
Number:
2680
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. B. Bukreeva, E. A. Dementieva, S. V. Nesterovich, G. A. Suchanova, G. N. Seitova (Tomsk, Russia). Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation. Eur Respir J 2003; 22: Suppl. 45, 2680
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Determinants of heightened systemic inflammation at exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006
Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD.
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Time course of systemic inflammatory markers during acute exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Investigation of the very early immune response in viral induced experimental asthma exacerbation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Local and systemic inflammation in acute viral exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Acceleration of neutrophilic inflammation during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency
Source: ERS Lung Science Conference 2021
Year: 2021
Comparison of the inflammatory response between two chronic models of allergic lung inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007
Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept